Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus. (Q50996678)
Jump to navigation
Jump to search
scientific article published on 14 May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus. |
scientific article published on 14 May 2013 |
Statements
1 reference
Pharmacokinetics and pharmacodynamics of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in subjects with type 2 diabetes mellitus. (English)
1 reference
Damayanthi Devineni
1 reference
Christopher R Curtin
1 reference
David Polidori
1 reference
Maria J Gutierrez
1 reference
Joseph Murphy
1 reference
Sarah Rusch
1 reference
Paul L Rothenberg
1 reference
14 May 2013
1 reference
53
1 reference
601-610
1 reference
6
1 reference
Identifiers
1 reference
1 reference